ARTORG Center for Biomedical Engineering Research

Aussenansicht Gebäude des ARTORG Centers

The Center creates innovative healthcare technology by bringing together the biomedical engineering and medicine departments of the University of Bern. Technical and clinical experts lead ARTORG’s multidisciplinary research units, addressing the unmet needs of patients, doctors, and nurses at the interface of technology and medicine.

To the ARTORG website

Director

Prof. Raphael Sznitman
Artificial Intelligence in Medical Imaging Laboratory
ARTORG Center for Biomedical Engineering Research

Profile

  • In its 17th year, the ARTORG Center hosts 13 independent research groups, 5 of them at sitem-insel, covering Artificial Intelligence, Biomechanics, Organs-on-Chip, Rehabilitation, Robotics, Surgical Technologies, Virtual and Augmented Reality
  • Service facilities in biomechanical testing, clinical research databases, medical rapid prototyping, biomicrofabrication, scientific computing, and custom component manufacturing.
  • With its clinical partners, ARTORG tackles unmet healthcare needs in diagnosis, monitoring, treatment, and rehabilitation, and actively shapes the digitalized healthcare future through targeted approaches.
  • Longstanding experience in translation, clinical validation, and commercialization of MedTech research in Bern and beyond, including seven start-up spinouts with recognized excellence and three MedTech Award wins.
  • Teaching: Master’s programs AI in Medicine & Biomedical Engineering, postgraduate program Cellular and Biomedical Sciences, electives in digitalization and AI for medical students, specialist courses for clinicians in collaboration

External Partners

Universität Bern, Inselspital, sitem-insel, Universitäre Psychiatrische Dienste, 3RCC, Alexis, AlveoliX, AO Research Institute, Berner Fachhochschule, Bristol Urological Institute, CASCINATION, Charite - Universitätsmedizin Berlin, CHUV, Cochlear, CorFlow, cost European Cooperation in Science and Technology, CSEM, Debiotech, DomoHealth, EMPA, EPFL, ETHZ, Eurice, European Commission, Eurostars, Fondaction contre le Cancer, Hasler Stiftung, HE-ARC, Helmholtz, Hochschule Luzern HSLU, HORIZON 2020, Ikerian, Imperial College, Innosuisse, Intuitive Surgical, IROC, JDRF, Johnson & Johnson, Kantonsspital Luzern, Karolinska Institute, Krebsliga Schweiz, Lausanne University Hospital, LEM Surgical, Maastricht University, McGill University, MED-EL, Medical University Graz, Mount Sinai, New York, National and Kapodistrian University of Athens, Neosoma, Nordsjaellands Hospital, Novostia, Oslo University Hospital, Ostschweizer Fachhochschule, Paul Scherrer Institut, PeriVision, Platform for Advanced Scientific Computing, Politecnico Milano, Profil, Qumea, Reha Rheinfelden, Reha Zihlschlacht, Sanitas, SBFI, Siemens Healthineers, Sonova, Stanford Medicine, Stiftung Lindenhof, SurgeonsLab, Swiss National Science Foundation, Technische Universität München, Technische Universität Wien, Uni Bern Forschungsstiftung, Universität Basel, Universität Tübingen, Universitätsklinikum Freiburg, Universitätsklinikum Magdeburg, Universitätsspital Zürich, Universiteit Leiden, University Children’s Hospital (UKBB), University Hospital Antwerp, University Hospital Düsseldorf, University Hospitals Geneva (HUG), University of British Columbia, University of Groningen, University of Lausanne, University of Oxford, University of Southampton, University of Texas at Austin, University of Tokyo, URODEA, Varian, Vitrocell, Zahnmedizinische Kliniken, Zeiss, Ziemer Ophthalmology

Grants

  • SNSF Grants: BRIDGE Discovery – Patient-specific hydrogel-based corneal augmentation for vision restoration (Philippe Büchler, CBE), PolAInsight: Cancer detection in biopsy tissue with AI-based automated Mueller Matrix polarimetry (Raphael Sznitman, AIMI); BRIDGE Proof-of-Concept – SurgExplore: AI-Powered Surgical Training, Reporting, and Discovery (Negin Ghamsarian, AIMI), ReShape: New Frontiers in Corneal Cross-Linking (Matteo Frigelli, CBE); Spark – Sonifying Tinnitus from EEG Signals (Philipp Aebischer, HRL), Through a New Lens: Injectable Stroma for Vision Correction (Matteo Frigelli, CBE), Reinforcing Articular Cartilage: A Novel Approach Using Riboflavin-Induced Crosslinking (Tatiana Kochetkova, MSB); MAPS – AI-based Brain Metastases Tracking and Segmentation - A-BEACON (Mauricio Reyes, MIA)
  • Innosuisse Projects: Flagship Initiatives – SwissBrAInHealth (Tobias Nef, GER)
  • UniBE Funding: Venture Fellowships – DextEgg (Samuel Knobel, GER), ContourAid (Amith J. Kamath, MIA); INNO Grant – DextEgg (Nic Krummenacher, GER)

Highlights 2025

SONOSTENT – Ultrasound and cilia to clean implanted stents and catheters

Researchers from the University of Bern, Inselspital, Bern University Hospital, and ETH Zurich have developed an innovative technology which can clean implanted medical devices such as ureteral stents and catheters non-invasively, using ultrasound activation through the skin. In a recent study led by PD Dr. Francesco Clavica from the ARTORG Center for Biomedical Engineering Research the interdisciplinary team mimicked the architecture and flow conditions of stented ureters and proved that ultrasound-activated artificial cilia on the stent's surface can efficiently remove biofilms and encrustations.

To the Media Release of the University

Amado et al., Proc Natl Acad Sci U S A. 2025

Neosoma GmbH Incorporation

In 2019, Neosoma established a close research and development collaboration with the University of Bern, centered around a long-term licensing agreement leveraging deep learning technology developed at the university’s ARTORG Center for Biomedical Engineering Research. In January 2025, a wholly-owned subsidiary in Bern, Neosoma GmbH, was incorporated.

To the article on the ARTORG Website

EssilorLuxottica acquires RetinAI AG

Founded in 2017 by ARTORG researchers led by Dr Carlos Ciller, RetinAI developed the RetinAI Discovery® platform, a certified AI based system for ophthalmic image and data management that supports clinics, life science partners, and device manufacturers worldwide. In October 2025, RetinAI was acquired by EssilorLuxottica S.A., a global leader in vision care and optical innovation.

To the article on the ARTORG Website

4 SNSF BRIDGE Grants for ARTORG

Researchers from the AI in Medical Imaging Lab (AIMI) and from the Computational Bioengineering Group (CBE) have been granted two BRIDGE Discovery and two BRIDGE Proof-of-Concept grants. Raphael Sznitman (AIMI) and Philippe Büchler (CBE), heads of their respective groups, have received the Discovery grants, and Negin Ghamsarian (AIMI) and Matteo Frigelli (CBE), were awarded the Proof-of-Concept grants for their projects.

To the article on the ARTORG Website

To the SNF Website

Innosuisse Flagship Initiatives – SwissBrAInHealth

Bernese researchers are involved in all four consortia supported by Innosuisse as part of its call for "Flagship Initiatives". The University of Bern is the leading house for the Innosuisse Flagship Initiative "SwissBrAInHealth" under the co-leadership of Prof. Dr. Bogdan Draganski from the Department of Neurology - Brain Health Clinic at Inselspital, Bern University Hospital and Prof. Dr. Tobias Nef, from the ARTORG Center for Biomedical Engineering Research at the University of Bern.

To the article on the ARTORG Website